Company news
Anatara Lifesciences Ltd news in 2023
Anatara Lifesciences Ltd's news releases, calls and decks from 2023, newest first.
Entitlement Offer Results
December 6, 2023
Non-Renounceable Entitlement Offer Booklet
November 13, 2023
Entitlement offer opens and dispatch of Offer Booklet
November 13, 2023
AGM Chair Address
November 9, 2023
GaRP Clinical Trial AGM Presentation
November 9, 2023
Cleansing Notice
November 2, 2023
Anatara launches a partially underwritten Entitlement Offer
November 2, 2023
Appendix 4C & Q1 FY24 Activities Report
October 31, 2023
Webinar Investor Presentation
October 18, 2023
Anatara IBS trial positive secondary endpoint data analysis
October 16, 2023
ANR announces Positive Results from Stage 1 of IBS trial
September 28, 2023
IBS clinical trial Stage 1 patients finalised
August 30, 2023
Appendix 4E & Audited Financial Statements 30 June 2023
August 23, 2023
$923,235 in R&D tax incentive received
August 13, 2023
Appendix 4C & Q4 FY23 Activities Report
July 31, 2023
Anatara Update on GaRP Irritable Bowel Syndrome Trial
June 5, 2023
Appendix 4C & Q3 FY23 Activities Report
April 19, 2023
Anatara Company Update
March 9, 2023
Half Yearly Report and Accounts
February 23, 2023
Placement of Shortfall from Entitlement Offer
February 21, 2023
Revised Appendix 4C
January 13, 2023
Appendix 4C & Q2 FY23 Activities Report
January 11, 2023
Decks in 2023
- Shareholder Meeting (November 2023)
Shareholder meeting · 14 slides · Nov 10, 2023
- Investor Presentation (October 2023)
Investor deck · 30 slides · Oct 19, 2023
- Investor Presentation (May 2023)
Investor deck · 20 slides · May 8, 2023